Chiesi Limited, the UK affiliate of Italian healthcare company Chiesi Farmaceutici, has launched a new mobile app for adult patients with asthma or chronic obstructive pulmonary disease (COPD) to ...

Switching patients to a beclomethasone/formoterol inhaler can significantly boost asthma control and reduce costs, suggests a new study. The study found using a ...

Drug firm Lupin on Monday said its UK subsidiary has received approval from the regulatory authority to market Luforbec pressurised metered dose inhaler used for regular treatment of asthma in the UK ...

Chiesi is working with the BBC to show off its climate-conscious credentials, partnering with the British broadcaster on a web series episode about redesigning inhalers to reduce their environmental ...